
Antibody Oligonucleotide Conjugates as a New Frontier in Genetic Disease Therapy
Download the full article (PDF) Introduction Antibody oligonucleotide conjugates (AOCs) represent an emerging class of biotherapeutics that combine the cell-targeting precision of antibodies with the gene-modulating capabilities of oligonucleotides. Structurally,














